The European drug discovery informatics market is estimated to grow significantly at a CAGR of 8.6% during the forecast period owing to the growing pharmaceutical R&D in the region coupled with the significant adoption of analytics solutions in drug discovery. This growth in pharmaceutical R&D results in the growing number of drug discovery and development, which in turn, is leading the demand for informatics solutions in the region. The European drug discovery informatics market is segmented based on function and end-user. Based on the technology, the market is further classified into docking, molecular modeling, libraries & database preparation, sequencing & target data analysis, and others. The sequencing & target data analysis segment is projected to have considerable growth during the forecast period.
Based on the end-user, the European drug discovery informatics market is further segmented into pharmaceutical & biotechnology companies, contract research organizations, and others. The pharmaceutical & biotechnology companies’ segment is estimated to have a significant share in the market. Based on geography, the European drug discovery informatics market is further segregated into the UK, Germany, France, Italy, Spain, and the Rest of Europe (Russia, Poland, Sweden, and other economies).
Furthermore, the European drug discovery informatics market is characterized by the presence of several market players that are catering to a wide range of customers in the region. Some of the key players in the market include Accenture PLC, Dassault Systèmes SE, Eurofins GSC Lux SARL, Evotec SE, Selvita S.A, and others. These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launches, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.
Research Methodology
The market study of the European drug discovery informatics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for drug discovery analytics market players, contract research organizations, biotechnology and pharmaceutical companies, industry associates & experts, government organizations, regulatory bodies, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Drug Discovery Informatics Market by Function
5.1.1. Docking
5.1.2. Molecular Modeling
5.1.3. Libraries and Database Preparation
5.1.4. Sequencing and Target Data Analysis
5.1.5. Others
5.2. European Drug Discovery Informatics Market by End-User
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Contract Research Organization (CRO)
5.2.3. Others (Research Institutes)
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. France
6.4. Italy
6.5. Spain
6.6. Rest of Europe
7. Company Profiles
7.1. Accenture PLC
7.2. Charles River Laboratories, Inc.
7.3. Cognizant Function Solutions Corp.
7.4. Domainex
7.5. Dassault Systèmes SE
7.6. Eurofins GSC Lux SARL
7.7. Evotec SE
7.8. Infosys Ltd.
7.9. IBM Corp.
7.10. Selvita S.A.
1. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
2. EUROPEAN DOCKING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
3. EUROPEAN MOLECULAR MODELING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
4. EUROPEAN LIBRARIES & DATABASE PREPARATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
5. EUROPEAN SEQUENCING AND TARGET DATA ANALYSIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
6. EUROPEAN OTHERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
7. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
8. EUROPEAN DRUG DISCOVERY INFORMATICS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. EUROPEAN DRUG DISCOVERY INFORMATICS IN CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
10. EUROPEAN DRUG DISCOVERY INFORMATICS IN OTHER END-USER MARKET RESEARCH AND ANALYSIS BY COUNT RY, 2019-2026 ($ MILLION)
11. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
12. UK DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
13. UK DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
14. GERMANY DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
15. GERMANY DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
16. FRANCE DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
17. FRANCE DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
18. ITALY DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
19. ITALY DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
20. SPAIN DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
21. SPAIN DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
22. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY FUNCTION, 2019-2026 ($ MILLION)
23. REST OF EUROPE DRUG DISCOVERY INFORMATICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
1. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET SHARE BY FUNCTION, 2019 VS 2026 (%)
2. EUROPEAN DOCKING MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
3. EUROPEAN MOLECULAR MODELING MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
4. EUROPEAN LIBRARIES & DATABASE PREPARATION MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
5. EUROPEAN SEQUENCING AND TARGET DATA ANALYSIS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
6. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET SHARE BY END-USER, 2019 VS 2026 (%)
7. EUROPEAN DRUG DISCOVERY INFORMATICS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
8. EUROPEAN DRUG DISCOVERY INFORMATICS IN CONTRACT RESEARCH ORGANIZATION MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
9. EUROPEAN DRUG DISCOVERY INFORMATICS IN OTHER END-USER MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
10. EUROPEAN DRUG DISCOVERY INFORMATICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
11. UK DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)
12. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)
13. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)
14. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)
15. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF EUROPEAN DRUG DISCOVERY INFORMATICS MARKET SIZE, 2019-2026 ($ MILLION)